Improving Performance in Drivers With Mild Cognitive Impairment

NCT01935219 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2020-01-21

No results posted yet for this study

Summary

The objective of this study is to assess the effectiveness of an intervention to address both executive function and processing speed changes that contribute to poor driving performance in adults with Mild Cognitive Impairment (MCI).

Our hypotheses are that the study intervention will improve performance on a driving simulator and will improve (i) executive function, specifically attention and planning, (ii) useful field of view, (iii) mood, (iv) quality of life, and (v) reported motor vehicle crashes and driving infractions.

Conditions

Interventions

BEHAVIORAL

Goal Management Training

9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer

BEHAVIORAL

Processing Speed Training

9 weeks, a total of 10 hours of computer-based processing speed training; 60-75 minutes/week

BEHAVIORAL

Brain Health Workshop

9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer

Sponsors & Collaborators

  • Unity Health Toronto

    collaborator OTHER
  • Sunnybrook Health Sciences Centre

    collaborator OTHER
  • Lakehead University

    collaborator OTHER
  • McGill University

    collaborator OTHER
  • University Health Network, Toronto

    collaborator OTHER
  • Michael Garron Hospital

    collaborator OTHER
  • Centre for Addiction and Mental Health

    collaborator OTHER
  • Baycrest

    lead OTHER

Principal Investigators

  • Gary Naglie, MD · Baycrest

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01935219 on ClinicalTrials.gov